Artivion, Inc. (NYSE: AORT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
Artivion, Inc. (AORT)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Those who invested in Artivion (NYSE:AORT) a year ago are up 61% [Yahoo! Finance]Yahoo! Finance
- Artivion, Inc. (NYSE: AORT) had its price target raised by analysts at Stifel Nicolaus from $28.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)? [Yahoo! Finance]Yahoo! Finance
- Should You Invest in Artivion (AORT)? [Yahoo! Finance]Yahoo! Finance
- Organ and Tissue Transplantation Strategic Research Report 2023-2030: Rising Focus on Immunosuppressive Therapies Strengthens Business Case for Post-Transplant Care [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 8/8/24 - Beat
AORT
Sec Filings
- 8/27/24 - Form 4
- 8/26/24 - Form 144
- 8/19/24 - Form 4
- AORT's page on the SEC website